Merifin Capital is a European private investment company focused on traditional and alternative asset classes.
Business Model:
Revenue: $0
Employees: 0-0
Address: Place Flagey 18
City: Brussels
State: brussels-capital region
Zip: B-1050
Country: BE
Merifin Capital is an experienced European private investment group with offices and executives operating in: Brussels Geneva New York London Merifin Capital has successfully invested in traditional and alternative asset classes for a period of over twenty years. At the present time, Merifin Capital and its affiliates manage a substantial investment portfolio and maintain an active investment program.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2004 | immatics biotechnologies | Series A | 0 |
8/2008 | F2G | Venture Round | 11.8M |
1/2003 | Optiva | Series C | 0 |
1/2004 | Cyclacel Pharmaceuticals | Series D | 38.7M |
9/2015 | DoveConviene | Series C | 0 |
12/2014 | DoveConviene | Series B | 0 |
11/2013 | Flayr | Series A | 0 |
1/2007 | Plastic Logic Germany | Series D | 0 |
9/2012 | F2G | Equity | 30M |
11/2005 | Metara | Series E | 0 |
6/2016 | F2G | Series E | 60M |
1/2005 | DanioLabs | Series A | 0 |
6/2016 | F2G | Private Equity Round | 0 |
9/2015 | DoveConviene | Series C | 0 |
12/2014 | DoveConviene | Series B | 0 |
11/2013 | Flayr | Series A | 0 |
9/2012 | F2G | Venture Round | 0 |
8/2008 | F2G | Venture Round | 0 |
1/2007 | Plastic Logic Germany | Series D | 0 |
11/2005 | Metara | Series E | 0 |
1/2005 | DanioLabs | Series A | 0 |
2/2004 | immatics biotechnologies | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|